JP2011500537A5 - - Google Patents

Download PDF

Info

Publication number
JP2011500537A5
JP2011500537A5 JP2010528414A JP2010528414A JP2011500537A5 JP 2011500537 A5 JP2011500537 A5 JP 2011500537A5 JP 2010528414 A JP2010528414 A JP 2010528414A JP 2010528414 A JP2010528414 A JP 2010528414A JP 2011500537 A5 JP2011500537 A5 JP 2011500537A5
Authority
JP
Japan
Prior art keywords
methyl
pyrrolidinyl
chlorophenyl
alkyl
compound according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP2010528414A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011500537A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2008/063642 external-priority patent/WO2009047336A1/en
Publication of JP2011500537A publication Critical patent/JP2011500537A/ja
Publication of JP2011500537A5 publication Critical patent/JP2011500537A5/ja
Ceased legal-status Critical Current

Links

JP2010528414A 2007-10-11 2008-10-10 Ｈ１受容体アンタゴニストとしてのフタラジンおよびピリド［３，４−ｄ］ピリダジン化合物 Ceased JP2011500537A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US97910507P 2007-10-11 2007-10-11
PCT/EP2008/063642 WO2009047336A1 (en) 2007-10-11 2008-10-10 Phthalazine and pyrido [3,4-d] pyridaz ine compounds as h1 receptor antagonists

Publications (2)

Publication Number Publication Date
JP2011500537A JP2011500537A (ja) 2011-01-06
JP2011500537A5 true JP2011500537A5 (https=) 2011-12-01

Family

ID=40104668

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010528414A Ceased JP2011500537A (ja) 2007-10-11 2008-10-10 Ｈ１受容体アンタゴニストとしてのフタラジンおよびピリド［３，４−ｄ］ピリダジン化合物

Country Status (6)

Country Link
US (1) US20100216799A1 (https=)
EP (1) EP2215082B1 (https=)
JP (1) JP2011500537A (https=)
AT (1) ATE525370T1 (https=)
ES (1) ES2369320T3 (https=)
WO (1) WO2009047336A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006115221A1 (ja) * 2005-04-21 2006-11-02 Nippon Shinyaku Co., Ltd. フタラジノン誘導体及びその医薬
DK2120579T3 (da) * 2006-12-28 2014-02-03 Abbvie Inc Inhibitorer af poly(ADP-ripose)polymerase
US8097620B2 (en) * 2007-05-04 2012-01-17 Amgen Inc. Diazaquinolones that inhibit prolyl hydroxylase activity
PH12022551513A1 (en) 2019-12-20 2023-04-24 Mirati Therapeutics Inc Sos1 inhibitors

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3813384A (en) * 1972-01-17 1974-05-28 Asta Werke Ag Chem Fab Basically substituted benzyl phthalazone derivatives,acid salts thereof and process for the production thereof
PH23995A (en) * 1984-01-09 1990-02-09 Janssen Pharmaceutica Nv 4((bicycle heterocyclyl)-methyl and hetero)piperidines
EP0174464B1 (de) * 1984-09-14 1990-01-03 ASTA Pharma AG Substituierte Benzylphthalazinon-Derivate
DE3677322D1 (de) * 1985-11-11 1991-03-07 Asta Pharma Ag 4-benzyl-1-(2h)-phthalazinon-derivate.
DE3634942A1 (de) * 1985-11-11 1987-05-14 Asta Werke Ag Chem Fab Neue 4-benzyl-1-(2h)-phthalazinon-derivate
EP0289939A1 (de) * 1987-05-08 1988-11-09 ASTA Pharma AG Neue 4-Benzyl-1-(2H)-phthalazinon-Derivate mit einem Aminosäurerest
CZ199593A3 (en) * 1992-10-02 1994-04-13 Asta Medica Ag Phthalazinone derivatives exhibiting anti-arrhythmic and analgesic activity and eliminating resistance to a plurality of medicaments (mdr)
US6180629B1 (en) * 1998-08-14 2001-01-30 Cell Pathways, Inc. [4,5]-Fused-1,3-disubstituted-1,2-diazine-6-one derivatives with nitrogen containing substitutents in position one for the treatment of neoplasia
EP0997474B1 (en) * 1998-08-14 2003-10-29 Pfizer Inc. Antithrombotic agents
US20030073692A1 (en) * 2001-08-07 2003-04-17 Pharmacia & Upjohn S.P.A. Amino-phthalazinone derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them
WO2004082682A1 (en) * 2003-03-18 2004-09-30 Merck & Co. Inc. Amino cyclobutylamide modulators of chemokine receptor activity
EP1642898B1 (en) * 2003-06-27 2013-03-27 Msd K.K. Heteroaryloxy nitrogenous saturated heterocyclic derivative
ATE459358T1 (de) * 2006-12-20 2010-03-15 Glaxo Group Ltd 4-benzyl-1(2h)-phthalazinone als h1-rezeptor- antagonisten

Similar Documents

Publication Publication Date Title
RU2436780C2 (ru) Производные 5-фенилтиазола и их применение в качестве ингибиторов рi3 киназы
JP2009536620A5 (https=)
RU2342383C2 (ru) ПРОИЗВОДНЫЕ ИМИДАЗОЛ-4-ИЛЭТИНИЛПИРИДИНА, СПОСОБ ИХ ПОЛУЧЕНИЯ (ВАРИАНТЫ) И ПРИМЕНЕНИЕ В КАЧЕСТВЕ АНКСИОЛИТИКА, ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ И СПОСОБ ЛЕЧЕНИЯ НАРУШЕНИЙ, ОПОСРЕДУЕМЫХ РЕЦЕПТОРОМ mGLuR5
SI2961736T1 (en) Histone demethylase inhibitors
JP2016538313A5 (https=)
RU2015105561A (ru) Замещенные гетероазепиноны
JP2010509356A5 (https=)
JP2014528433A5 (https=)
RU2012116877A (ru) Соединения 2-пиридона, применяемые в качестве ингибиторов нейтрофильной эластазы
JP2014502979A5 (https=)
JP2017504642A5 (https=)
JP2005536475A5 (https=)
RU2013112122A (ru) Новые замещенные хинолиновые соединения как ингибиторы s-нитрозоглутатион-редуктазы
JP2015531773A (ja) スルファモイル−アリールアミド及びｂ型肝炎の治療のための薬剤としてのその使用
JP2008504266A5 (https=)
JP2018515525A5 (https=)
RU2013138569A (ru) Антагонисты рецептора минералокортикоидов
RU2014152790A (ru) Пирролопиразоновые ингибиторы танкиразы
JP2007502265A5 (https=)
RU2017126187A (ru) 5-[(пиперазин-1-ил)-3-оксо-пропил]-имидазолидин-2,4-дионовые производные в качестве ингибиторов adamts для лечения остеоартрита
JP2010513393A5 (https=)
RU2014113679A (ru) N-(2-амино-6,6-дифтор-4,4а,5,6,7,7а-гексагидро-циклопента[e][1,3]оксазин-4-ил)-фенил)-амиды в качестве ингибиторов бета-секретазы 1
RU2008120850A (ru) Соединения и композиции в качестве ингибиторов протеинкиназ
JP2007520440A5 (https=)
JP2013533253A5 (https=)